The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study

A. Modi*, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellstrom, J. P. Weaver, J. P. van den Bergh, P. Keown, S. Sajjan

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalOsteoporosis International
Volume29
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Adherence
  • Gastrointestinal events
  • Medication
  • Osteoporosis
  • Persistence
  • POSTMENOPAUSAL WOMEN
  • BISPHOSPHONATE THERAPY
  • CLINICAL-PRACTICE
  • FRACTURE RISK
  • ORAL BISPHOSPHONATES
  • MEDICATION ADHERENCE
  • ALENDRONATE THERAPY
  • DATABASE ANALYSIS
  • UNITED-STATES
  • DETERMINANTS

Cite this